Who makes BB4 antibody-Iodine 131?

BB4 antibody-Iodine 131 is developed by Centre René Gauducheau.

What development phase is BB4 antibody-Iodine 131 in?

BB4 antibody-Iodine 131 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

BB4 antibody-Iodine 131

Centre René Gauducheau · Phase 1 active Small molecule

At a glance

Generic name	BB4 antibody-Iodine 131
Sponsor	Centre René Gauducheau
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BB4 antibody-Iodine 131 CI brief — competitive landscape report
BB4 antibody-Iodine 131 updates RSS · CI watch RSS
Centre René Gauducheau portfolio CI